首頁 > 市場調查報告書 > 醫療設備

生技設備 3D列印

市場調查報告書

商品編碼

1390729

2023-2028 年按組件（3D 生物列印機、支架、生物材料）、應用（研究、臨床）、最終用戶（醫院、研究組織和學術機構、生物製藥公司）和地區分類的 3D 生物列印市場報告

3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2023-2028

出版日期: 2023年11月24日 | 出版商:

IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年，全球3D生物列印市場規模達到10.32億美元。展望未來， IMARC Group預計到2028年市場規模將達到26.21億美元，2022-2028年複合年成長率（CAGR）為16.81%。不斷成長的老年人口、對研發 (R&D) 活動的日益關注以及市場干擾的減少是推動市場發展的一些關鍵因素。

老年人口增加促進市場成長

目前，老年人口的成長是推動 3D 生物列印市場的主要因素之一。老年人群更容易患慢性病，因此對器官移植的需求增加。此外，各種醫療技術的廣泛應用以及業內有能力的專家的存在正在支持市場的成長。

報告涵蓋了市場結構、主要參與者的市場佔有率、參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。市場結構適度分散，該行業存在許多區域和全球參與者。由於資本投資高、進入和退出障礙過高，3D生物列印產業的新進入者數量適中。此外，由於幾家製造商之間差異不大，因此行業內產品差異化程度適中。

什麼是 3D 生物列印？

3D（3D）生物列印是一種專為開發精確解剖組織而設計的積層製造方法。它包括各種沉積和組裝工藝，例如直接寫入和雷射寫入、微沖壓、光刻、立體光刻、電子印刷和噴墨沉積。它依賴於使用活細胞、生物材料和活性生物分子製造的基於細胞的生物墨水的分解，以創建組織和器官的 3D 結構。它沉積多層生物材料來建造許多複雜的身體結構，如骨骼、皮膚、軟骨、血管移植物、氣管夾板和心臟組織。因此，3D生物列印在全球的醫院、研究機構、學術機構和生物製藥公司已被廣泛應用。

COVID-19 影響：

COVID-19大流行的疫情為各行業帶來了嚴重問題，也為許多國家帶來了前所未有的挑戰。但在 COVID-19 大流行期間，3D 生物列印已成為醫療保健產業的重要技術。由於醫療產品無法取得或短缺，對 3D 生物列印器官的需求增加。除此之外，多家公司正在使用最先進的 3D 生物列印平台來製造 SARS-CoV-2 感染的人類氣道和肺部類器官模型。此外，這些模型也被用於研究 COVID-19 疾病進展和快速藥物篩選。由於全球 COVID-19 病例不斷增加，生物印表機的使用率增加。除此之外，由於生產過程的減少，疫情對3D生物列印市場造成了輕微的阻礙。由於病毒的廣泛傳播，在大流行的頭幾個月裡，各個主要製造商被迫暫時關閉或暫停其生產過程。

3D生物列印市場趨勢：

目前，消費者減少動物試驗的意識不斷增強，這是積極影響市場的主要因素之一。除此之外，老年族群更容易患各種慢性病，因此對 3D 生物列印的需求不斷成長，這提供了積極的市場前景。此外，各種技術進步，例如器官晶片的發展，正在推動市場的成長。除此之外，世界各地大眾對再生醫學、癌症治療和幹細胞解決方案日益成長的需求也促進了市場的成長。此外，醫療保健行業中 3D 生物列印的採用率不斷上升，因為這是一個受干擾較少的市場，正在支持市場的成長。此外，主要製造商正專注於研發（R＆D）活動，以引入生物列印組織，以降低新創新的成本並加快尋找新藥的過程。

本報告回答的關鍵問題

2022年全球3D生物列印市場規模有多大？
2023-2028年全球3D生物列印市場的預期成長率是多少？
推動全球3D生物列印市場的關鍵因素是什麼？
COVID-19 對全球 3D 生物列印市場有何影響？
基於組件的全球 3D 生物列印市場的詳細情形如何？
基於應用的全球3D生物列印市場的詳細情形如何？
基於最終用戶的全球 3D 生物列印市場的詳細情形如何？
全球3D生物列印市場的重點區域有哪些？
全球 3D 生物列印市場的主要參與者/公司有哪些？

3D生物列印機
- 市場走向
- 關鍵環節
  - 注射器/擠出生物列印
  - 噴墨生物列印
  - 磁浮生物列印
  - 雷射輔助生物列印
  - 其他
- 市場預測
鷹架
- 市場走向
- 市場預測
生物材料
- 市場走向
- 關鍵環節
  - 活細胞
  - 水凝膠
  - 細胞外基質
  - 其他
- 市場預測

第 7 章：按應用分類的市場區隔

研究
- 市場走向
- 關鍵環節
  - 藥物研究
  - 再生醫學
  - 3D 細胞培養
- 市場預測
臨床
- 市場走向
- 關鍵環節
  - 皮膚
  - 骨骼和軟骨
  - 血管
  - 其他
- 市場預測

第 8 章：最終用戶的市場區隔

醫院
- 市場走向
- 市場預測
研究機構及學術機構
- 市場走向
- 市場預測
生物製藥公司
- 市場走向
- 市場預測

第 9 章：按地區分類的市場區隔

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 10 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 13 章：價格分析

第14章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- 3D Systems Inc.
- Aspect Biosystems Ltd.
- Cellink
- Cyfuse Biomedical KK
- EnvisionTEC GmbH (Desktop Metal Inc.)
- GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
- Materialise
- Organovo Holdings Inc.
- Poietis
- RegenHU
- Stratasys Ltd.

簡介目錄圖表

Product Code: SR112023A4556

Abstract

The global 3D bioprinting market size reached US$ 1,032 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,621 Million by 2028, exhibiting a growth rate (CAGR) of 16.81% during 2022-2028. The growing geriatric population, increasing focus on research and development (R&D) activities, and less disrupted market represent some of the key factors driving the market.

Rising Geriatric Population Augmenting Market Growth

The rising geriatric population currently represents one of the primary factors driving the 3D bioprinting market. There is an increase in the demand for organ transplantation among the geriatric population, as they are more prone to chronic diseases. Moreover, the wide availability of various medical technologies and the presence of competent specialists in the industry is supporting the growth of the market.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is moderately fragmented with the presence of numerous regional and global players in the industry. The volume of new entrants is moderate in the 3D bioprinting industry due to the high capital investments and excessive entry and exit barriers. Moreover, the product differentiation is moderate in the industry due to little differentiation between several manufacturers.

What is 3D Bioprinting?

Three-dimensional (3D) bioprinting refers to an additive manufacturing method designed for the development of precise anatomical tissues. It comprises various deposition and assembling processes, such as direct and laser writing, microstamping, photolithography, stereolithography, electro-printing, and inkjet deposition. It relies on the decomposition of cell-based bio-inks that are manufactured using living cells, biomaterials, and active biomolecules to create 3D structures of tissues and organs. It deposits multiple layers of biomaterials to build numerous complex bodily structures, such as bones, skin, cartilage, vascular grafts, tracheal splints, and heart tissues. As a result, 3D bioprinting is widely utilized in hospitals, research organizations, academic institutes, and biopharmaceutical companies across the globe.

COVID-19 Impact:

The COVID-19 pandemic outbreak caused severe problems for various industries and imposed unprecedented challenges on numerous countries. But 3D bioprinting has emerged as a vital technology in the healthcare industry during the COVID-19 pandemic. There was an increased demand for 3D bioprinted organs due to the unavailability or shortage of medical products. In addition to this, various companies were using state-of-the-art 3D bioprinting platforms to fabricate SARS-CoV-2-infected human airway and lung organoid models. Moreover, these models were being used to study COVID-19 disease progression and for rapid drug screening. There was an increased utilization of bioprinters on account of the rising COVID-19 cases across the globe. Apart from this, the pandemic has slightly hampered the 3D bioprinting market due to the reduction in the production process. Various key manufacturers were forced to temporarily shut down or pause their production process for the first few months of the pandemic due to the widespread of the virus.

3D Bioprinting Market Trends:

At present, the increasing awareness among consumers to minimize animal testing represents one of the major factors influencing the market positively. Besides this, the growing demand for 3D bioprinting among the geriatric population, as they are more prone to various chronic diseases, is offering a positive market outlook. In addition, various technological advancements, such as the development of organ-on-a-chip, is propelling the growth of the market. Apart from this, the increasing demand for regenerative medicines, cancer therapeutics, and stem cell solutions among the masses around the world is contributing to the growth of the market. Moreover, the rising adoption of 3D bioprinting in the healthcare industry, as it is a less disrupted market, is supporting the growth of the market. Furthermore, key manufacturers are focusing on research and development (R&D) activities to introduce bioprinted tissues to reduce the cost of new innovations and enhance the process of finding new drugs.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D bioprinting market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, application and end user.

Component Insights:

3D Bioprinters

Syringe/Extrusion Bioprinting

Inkjet Bioprinting

Magnetic Levitation Bioprinting

Laser-assisted Bioprinting

Others

Scaffolds

Biomaterials

Living Cells

Hydrogels

Extracellular Matrices

Others

The report has provided a detailed breakup and analysis of the 3D bioprinting market based on the component. This includes 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices, and others). According to the report, 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment due to the increasing utilization of syringe or extrusion-based bioprinting technology in printing various biological compounds or devices. In addition to this, the rising awareness among individuals about the 3D bioprinters technology is bolstering the growth of the market.

Application Insights:

Research

Drug Research

Regenerative Medicine

3D Cell Culture

Clinical

Skin

Bone and Cartilage

Blood Vessels

Others

A detailed breakup and analysis of the 3D bioprinting market based on the application has also been provided in the report. This includes research (drug research, regenerative medicine, and 3D cell culture) and clinical (skin, bone and cartilage, blood vessels, and others). According to the report, research (drug research, regenerative medicine, and 3D cell culture) accounted for the largest market share, as 3D printing technology is widely utilized among researchers to study the effects of different diseases and their progression and possible treatments. Moreover, it reduces the need to use lab animals for medical tests and dangerous trials on humans.

End User Insights:

Hospitals

Research Organization and Academic Institutes

Biopharmaceuticals Companies

A detailed breakup and analysis of the 3D bioprinting market based on the end user has also been provided in the report. This includes hospitals, research organization and academic institutes, and biopharmaceuticals companies. According to the report, biopharmaceuticals companies accounted for the largest market share due to the increasing number of target therapies. In addition, the rising collaborations and mergers among biopharmaceutical companies to develop 3D bioprinting is positively influencing the market.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting. Some of the factors driving the North America 3D bioprinting market included the growing prevalence of various chronic diseases, presence of key players, and increasing private and government investment. Moreover, the introduction of laser bio-printing method that can make live 3D printed bio-tissues to create artificial tissues is positively influencing the market.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global 3D bioprinting market. Some of the companies covered in the report include:

3D Systems Inc.

Aspect Biosystems Ltd.

Cellink

Cyfuse Biomedical K.K.

EnvisionTEC GmbH (Desktop Metal Inc.)

GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH

Materialise

Organovo Holdings Inc.

Poietis

RegenHU

Stratasys Ltd.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. What was the size of the global 3D bioprinting market in 2022?
2. What is the expected growth rate of the global 3D bioprinting market during 2023-2028?
3. What are the key factors driving the global 3D bioprinting market?
4. What has been the impact of COVID-19 on the global 3D bioprinting market?
5. What is the breakup of the global 3D bioprinting market based on the component?
6. What is the breakup of the global 3D bioprinting market based on the application?
7. What is the breakup of the global 3D bioprinting market based on the end user?
8. What are the key regions in the global 3D bioprinting market?
9. Who are the key players/companies in the global 3D bioprinting market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global 3D Bioprinting Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Component

6.1 3D Bioprinters
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Syringe/Extrusion Bioprinting
  - 6.1.2.2 Inkjet Bioprinting
  - 6.1.2.3 Magnetic Levitation Bioprinting
  - 6.1.2.4 Laser-assisted Bioprinting
  - 6.1.2.5 Others
- 6.1.3 Market Forecast
6.2 Scaffolds
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Biomaterials
- 6.3.1 Market Trends
- 6.3.2 Key Segments
  - 6.3.2.1 Living Cells
  - 6.3.2.2 Hydrogels
  - 6.3.2.3 Extracellular Matrices
  - 6.3.2.4 Others
- 6.3.3 Market Forecast

7 Market Breakup by Application

7.1 Research
- 7.1.1 Market Trends
- 7.1.2 Key Segments
  - 7.1.2.1 Drug Research
  - 7.1.2.2 Regenerative Medicine
  - 7.1.2.3 3D Cell Culture
- 7.1.3 Market Forecast
7.2 Clinical
- 7.2.1 Market Trends
- 7.2.2 Key Segments
  - 7.2.2.1 Skin
  - 7.2.2.2 Bone and Cartilage
  - 7.2.2.3 Blood Vessels
  - 7.2.2.4 Others
- 7.2.3 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Research Organization and Academic Institutes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Biopharmaceuticals Companies
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 3D Systems Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Aspect Biosystems Ltd.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Cellink
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Cyfuse Biomedical K.K.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 EnvisionTEC GmbH (Desktop Metal Inc.)
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Materialise
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
- 14.3.8 Organovo Holdings Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 Poietis
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 RegenHU
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 Stratasys Ltd.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: 3D Bioprinting Market: Major Drivers and Challenges
Figure 2: Global: 3D Bioprinting Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: 3D Bioprinting Market: Breakup by Component (in %), 2022
Figure 5: Global: 3D Bioprinting Market: Breakup by Application (in %), 2022
Figure 6: Global: 3D Bioprinting Market: Breakup by End User (in %), 2022
Figure 7: Global: 3D Bioprinting Market: Breakup by Region (in %), 2022
Figure 8: Global: 3D Bioprinting (3D Bioprinters) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: 3D Bioprinting (3D Bioprinters) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: 3D Bioprinting (Scaffolds) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: 3D Bioprinting (Scaffolds) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: 3D Bioprinting (Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: 3D Bioprinting (Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: 3D Bioprinting (Research) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: 3D Bioprinting (Research) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: 3D Bioprinting (Clinical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: 3D Bioprinting (Clinical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: 3D Bioprinting (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: 3D Bioprinting (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: North America: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: North America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: United States: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: United States: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Canada: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Canada: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Asia-Pacific: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Asia-Pacific: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: China: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: China: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Japan: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Japan: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: India: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: India: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: South Korea: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: South Korea: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Australia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Australia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Indonesia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Indonesia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Europe: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Europe: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Germany: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Germany: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: France: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: France: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: United Kingdom: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: United Kingdom: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Italy: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Italy: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Spain: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Spain: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Russia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Russia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Latin America: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Latin America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Brazil: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Brazil: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Mexico: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Mexico: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Middle East and Africa: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Middle East and Africa: 3D Bioprinting Market: Breakup by Country (in %), 2022
Figure 72: Middle East and Africa: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Global: 3D Bioprinting Industry: SWOT Analysis
Figure 74: Global: 3D Bioprinting Industry: Value Chain Analysis
Figure 75: Global: 3D Bioprinting Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: 3D Bioprinting Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: 3D Bioprinting Market Forecast: Breakup by Component (in Million US$), 2023-2028
Table 3: Global: 3D Bioprinting Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: 3D Bioprinting Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: 3D Bioprinting Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: 3D Bioprinting Market: Competitive Structure
Table 7: Global: 3D Bioprinting Market: Key Players

02-2729-4219

+886-2-2729-4219